ITGA6 and neoplasm: As expected, iSOX2 MB157 tumor cell xenografts showed decreased N1-ICD levels, but increased CD49f positive cells in particular in the invasive growing tumor mass and were resistant to GSI-mediated tumor growth inhibition (Figs. EV4I and Fig. 5G).